8004 ORAL Safety and Efficacy Outcomes in Heavily and Non-heavily Pretreated Patients With Recurrent Ovarian Cancer (ROC) After Single-agent Trabectedin Treatment – Pooled Analysis of Phase II Trials

✍ Scribed by Colombo, N.; Del Campo, J.M.; Sehouli, J.; Sessa, C.; Bidzinski, M.; Nieto, A.; Jiao, J.; Kurzedei^, C.; Boman, K.; Gonzalez-Martin, A.

• Book ID: 122060889
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 60 KB
• Volume: 47
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/S0959-8049(11)72092-5